First-of-its-kind CAR T clinical trial enrolls HER2+ breast cancer patients with brain metastases

October 30, 2018 | City of Hope

City of Hope is now enrolling patients in a phase 1 trial evaluating the safety and efficacy of CAR T cell therapy in patients with HER2+ breast cancer that has metastasized to the brain.

Continue Reading

Liquid Biopsy Pioneers, Changing the Diagnostic Paradigm

May 24, 2017 | City of Hope

Genetically targeted therapies are becoming standard in cancer therapy and clinicians at City of Hope are pioneering liquid biopsy, a new noninvasive way of obtaining samples to make strategic therapeutic decisions with less discomfort, and less risk to patients.

New Cysview Technology Aids in the Treatment of Bladder Cancer

May 18, 2017 | Katie Neith

Using a simple but unique approach to image bladder cancer cells called Cysview, physicians at City of Hope are getting a better look at tumors and other abnormalities within the organ.

Innovations in Bladder Cancer Treatment

May 16, 2017 | Abe Rosenberg

Bladder cancer is a stubborn disease. But the City of Hope surgeons and scientists working to eradicate bladder cancer are equally stubborn.

Study: Stem Cell Transplants May Lead to Cure for Some T1D Patients

March 7, 2017 | Letisia Marquez

Clinical trial shows promising results from risky procedure, identifies path for personalized therapies. The results were published recently in the journal, Frontiers in Immunology.

The Impact of the TGen Alliance

December 1, 2016 | City of Hope

In this Q and A, Steven T. Rosen, M.D., provost and chief scientific officer for City of Hope, answers questions about the importance of precision medicine in the fight against cancer and how the City of Hope and TGen alliance will advance research and treatment using this approach.

Alliance Brings More Firepower to the Fight Against Cancer

December 1, 2016 | City of Hope

City of Hope joins forces with the Translational Genomics Research Institute (TGen) to accelerate the speed with which scientists and clinicians can convert research discoveries into cures.

Cancer Insights: Molecular profiling unlocks tumor answers

October 27, 2016 | Sumanta K. Pal, M.D.

Molecular profiling, unlike any other type of controversial profiling in the news, is an extremely hot topic in cancer medicine today, and it’s going to have a huge impact on patients, physicians and payers.

NCI-MATCH Trial focuses on mutations for rare cancers, not tumor site

April 15, 2015 | Nicole Levine

Precision medicine is becoming a reality for cancers with genetic mutations that are practically household names, such as those behind some breast cancers and lung cancers. A new multicenter trial focuses on providing precision treatments for rare cancers based on genetics, not tumor site.

The dawn of precision medicine in oncology

March 16, 2015 | Sumanta Kumar Pal M.D.

"Tonight, I'm launching a new precision medicine initiative to bring us closer to curing diseases like cancer." These were the words of President Barack Obama on Jan. 20, 2015, during his State of the Union address .